ZEVRA THERAPEUTICS, INC. (ZVRA)

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Address

1180 CELEBRATION BOULEVARD, SUITE 103

CELEBRATION, FL 34747

Founded

2006

Number of Employees

69

Website

http://zevra.com

Buyback

Buyback Data	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	Average
$ Amount Purchased ($ in 000s )	-	-	-	-	-	-	-	$2,849	$4,766	$3,389	-	$3,668
Average Price	-	-	-	-	-	-	-	$8.90	$8.08	$5.09	-	$6.98
# Shares Purchased	-	-	-	-	-	-	-	320,161	589,792	665,739	-	525,231

Buyback Performance	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	Average
Total Return to Date	-	-	-	-	-	-	-	-21.3%	-13.4%	37.5%	-	0.2%
S&P 500 Return to Date	-	-	-	-	-	-	-	31.7%	37.3%	31.3%	-	33.4%
Excess Total Return	-	-	-	-	-	-	-	-53.0%	-50.6%	6.2%	-	-33.2%
Quartile Rank
Percentile Rank	-	-	-	-	-	-	-	30%	34%	76%	-	43%

Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.

Showing content blurred. Create an account to see more.

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)